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Abstract
We report the solubilization and characterization of the oocyte membrane receptor for insecticyanin, a blue biliprotein of
the hawkmoth Manduca sexta. The insecticyanin receptor was solubilized using 40 mM CHAPS. Strong binding affinity of
w125 x 2qI insecticyanin to its solubilized receptor was demonstrated to be heat-labile, pH-dependent, Ca -dependent, and
saturable. The binding was inhibited by excess unlabeled insecticyanin, but not by two other major hemolymph and oocyte
proteins, vitellogenin and lipophorin. The receptor for insecticyanin showed tissue specificity: it was present only in oocyte
membranes, not in membranes of fat body, midgut or ovariole sheath. The equilibrium data for the solubilized receptor, Kd
and B , were estimated to be 17 nM and 11.4 pmolrmg solubilized proteins, respectively. The results frommax
co-immunoprecipitation showed that the apparent molecular mass for the insecticyanin receptor is approximately 185 kDa
while chemical crosslinking of the insecticyanin–receptor complex revealed a product with a molecular mass near 103 kDa.
This suggests that the insecticyanin receptor has a multimeric structure, or that four receptor molecules can bind to one
insecticyanin tetramer.
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1. Introduction
The construction of insect eggs involves the inter-
nalization of proteins and lipids from the circulating
3  .Abbreviations: BS , bis sulfosuccinimidyl suberate; CHAPS,
w . x3- 3-cholamidopropyl -dimethylammoniol -1-propane sulfonate;
DMSO, dimethyl sulfoxide; DSS, disuccinimidyl suberate; DTSP,
 .dithiobis succinimidyl propionate ; HDLp, high density
lipophorin; Ins, insecticyanin; SDS-PAGE, sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis; Vg, vitellogenin
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hemolymph and this internalization process is thought
to be mediated in large part by membrane-associated
receptors. The principal protein component thus im-
ported is vitellogenin, a major storage protein used by
the developing embryo. It has been demonstrated that
numerous proteins other than vitellogenin are also
taken up from hemolymph by developing oocytes. In
the case of Lepidoptera, these include insecticyanin
 . w xIns 1 , other lipoproteins, microvitellogenin and
w xpigmented proteins 2,3 ; in the case of locusts, a
w xsmall protein 4 ; and in the case of mosquitoes,
w xproenzymes and other small proteins 5 . Current
efforts are under way to isolate and characterize
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endocytotic receptors of insect oocytes that are re-
sponsible for the sequestration of these hemolymph
proteins. The ultimate goal of these studies is to
design specific methods that interfere with the lig-
and–receptor interactions, which may provide new
ways to control insects that are harmful to humans.
Most attention has been directed toward isolation of
receptors for vitellogenin and other yolk proteins,
which has so far been accomplished for the locust
w xLocusta migratoria 6 , the mosquito Aedes aegypti
w x w x7 and the fruitfly Drosophila melanogaster 8 .
Very little is known about the detailed mechanism
for interactions between vitellogenins and their recep-
tors. One of the difficulties in working with a vitel-
w xlogenin receptor, or lipophorin receptor 9 is that the
ligand is a large, complex structure that contains
lipids, carbohydrates and polypeptides with extensive
post-translational modifications. This complicates de-
tailed studies of receptor–ligand interactions. We
therefore reasoned that if an endocytotic receptor for
a relatively small and well-characterized protein can
be found, future studies of the receptor–ligand inter-
actions will be facilitated. Ins, a blue hemolymph
protein of the hawkmoth Manduca sexta seems to be
an ideal candidate for this purpose.
Ins, providing camouflage for the larvae and the
w x w xeggs 10 , is synthesized in the epidermis 11 of
larvae. Then the major isoform is secreted into
w xhemolymph 12 , where it persists into the adult stage
w xand is incorporated into eggs 13,14 . Biochemical
w xstudies, including X-ray crystallography 15 and
chemical crosslinking reported in the current study,
indicated that Ins is a tetrameric protein composed of
w xidentical subunits with a mass of 21 378 Da 16 . The
w x w xamino acid sequence 16 and cDNA sequence 11 of
Ins have been determined. Using in vitro uptake,
binding assays and histological autoradiography, we
have previously demonstrated that the internalization
of Ins into the developing oocyte follows a receptor-
w xmediated endocytotic pathway 1 .
In this study we report the solubilization and fur-
ther characterization of the M. sexta oocyte receptor
for Ins. Our results show that the receptor is a 185
kDa protein that specifically binds Ins with high
affinity. Co-immunoprecipitation and chemical cross-
linking demonstrate that Ins and its receptor form a
multimeric complex with a molecular mass of about
1000 kDa.
2. Materials and methods
2.1. Animals
w xM. sexta was reared as previously described 17 .
Two-day-old adult female animals were used to pre-
pare solubilized oocyte membrane proteins.
2.2. Buffer designations and components
Affinity-column elution buffer: 0.1 M acetate, 0.5
 .M NaCl pH 4.0 ;
  .Binding buffer: 20 mM MES 2- N-morpholino
.ethanesulfonic acid , 150 mM NaCl, 5 mM CaCl2
 .  .and 1% BSA bovine serum albumin pH 7.0 ;
Lepidopteran saline: 110 mM KCl, 4 mM NaCl,
 .15 mM MgCl , 5 mM phosphate pH 6.5 .2
2.3. Solubilization of membrane proteins by detergent
Preliminary experiments were performed to deter-
mine the solubilizing capacities of different deter-
gents, Triton X-100, octyl-b-D-glucoside and CHAPS,
and the optimal concentration of the chosen deter-
gent, based on the protein recoveries from solubilized
membranes. While the differences between the deter-
gents in their effects on solubilization of membranes
were not significant, 40 mM of CHAPS gave slightly
higher membrane protein yield than 15 mM and 25
 .mM data not shown . Therefore 40 mM CHAPS was
used for subsequent solubilization of membrane pro-
teins in this study.
All operations were carried out at 08C unless
otherwise indicated. Membranes were prepared as
w xpreviously described 1 except that the buffer used to
wash membranes was the lepidopteran saline given
above instead of the binding buffer. After homoge-
nization of oocytes and removal of soluble proteins
by ultracentrifugation, the membrane preparation was
adjusted to a protein concentration of 5 mgrml with
 .lepidopteran saline. CHAPS 1 M in the same buffer
was added to a final concentration of 40 mM to
solubilize membrane proteins. The suspension was
kept on ice for 1 h with occasional vortexing, then
diluted to 15 mM CHAPS using lepidopteran saline,
followed by centrifugation at 100 000=g for 1 h,
48C. The supernatant containing solubilized proteins
was further diluted to 5 mM CHAPS, and was even-
( )Y. Kang et al.rBiochimica et Biophysica Acta 1324 1997 285–295 287
tually brought to a minimum volume using a Centri-
 .con-30 concentrator unit Amicon . The proteins were
aliquoted and stored at y808C. The solubilization of
membrane proteins from fat body, midgut and ovari-
ole sheath of M. sexta were performed as described
above.
2.4. Protein purification
Hemolymph was collected from female adults by
w x the ‘flushing out’ method 18 and centrifuged 8000
.=g, 48C to remove hemocytes. Established proce-
w xdures were then used to purify Ins 16 , vitellogenin
w x w x19 and high density lipophorin 20 , respectively.
Protein concentrations were determined spectrophoto-
 .metrically using the BCA bicinchoninic acid protein
 . w xassay kit Pierce 21 .
2.5. Iodination of proteins
Ins and solubilized oocyte membrane proteins were
125 radioiodinated with Na I 17.4 Cirmg, DuPont-New
.England Nuclear, Wilmington, DE , using iodobeads
 .Pierce , according to the manufacturer’s instructions.
1 mCi Na125I was used for iodinating 20–100 mg
protein and the incorporation efficiency was 5–20%.
2.6. Ins–receptor binding assays
The binding assay was designed following pub-
w xlished work 6,7,9 . All binding assays were per-
 .formed in polyethylene Eppendorf tubes 1.5 ml . A
typical incubation mixture consisted of 100 ml bind-
ing buffer containing 5 mM CHAPS, indicated
w125 xamounts of solubilized membrane proteins, I Ins,
or other proteins as indicated in the figure legends.
Nonspecific binding was determined by carrying out
the binding assay in the presence of a 75-fold excess
of unlabeled Ins in a parallel incubation. Each experi-
ment consisted of three determinations. After incuba-
tion at 48C for 90 min, the volume of each incubation
was brought to 1 ml by adding ice-cold binding
buffer. The diluted incubation mixture was then fil-
tered through a polyvinylidene fluoride membrane
with a pore size of 0.22 mm Millipore, GVWP
.02500 , which had been pre-incubated overnight at
48C with the binding buffer supplemented with 0.01%
w125 xIns to minimize nonspecific binding of I Ins to
filters. Each filter was washed six times using iced
binding buffer, 1 ml per wash. The washed filters
were then placed into a plastic counting vial and the
radioactivity remaining on the filters was measured in
a gamma counter Wallac 1282 High Energy Compu
.Gamma CS . The specific binding was calculated as
the difference between the total and nonspecific bind-
ing.
[125 ]2.7. Immunoprecipitation of I Ins–receptor com-
plex
In order to remove endogenous Ins remaining in
the membrane proteins, and to remove labeled mem-
brane components that might nonspecifically bind to
immune complexes or protein-A agarose gels, aliquots
of iodinated solubilized oocyte membrane proteins
were first kept in binding buffer lacking Ca2q for
several hours to dissociate the bound Ins from its
receptor. This solution was then incubated with anti-
bodies against Ins a gift from Dr. Ralph R. Martel,
.Biochemistry Department, University of Arizona at
48C for 2 h, followed by incubation with protein-A
agarose gel for 2 h. The mixture was centrifuged and
the supernatant was saved for the next round of
treatment. This process was repeated a total of three
times. The final supernatant was supplemented with
2q  .Ca to a final concentration of 5 mM and used in
the subsequent binding and immunoprecipitation ex-
periments. Typically the binding reaction consisted of
125 I-membrane proteins, Ins and 5 mM CHAPS to
.prevent aggregation of membrane proteins . The in-
 .cubation mixture 100 ml was kept at 48C for 90 min
with gentle shaking. 20 ml Ins antibodies was added
and incubated for another 2 h, at 48C. Then 50 ml of
 .  .50% vrv protein-A agarose suspension Sigma
was added and further incubated at 48C for 2 h. The
protein-A gel was pelleted in a microcentrifuge for
15 s and the supernatant was discarded. The pellet
was resuspended by briefly vortexing in 0.5 ml bind-
ing buffer containing 0.01% Ins and subjected to
centrifugation again. This washing step was repeated
4–5 times until the radioactivity in the supernatant
was barely detectable. The last washed protein-A
pellet was violently vortexed in 50 ml SDS-PAGE
sample buffer for 30 s and boiled for 15 min. The
resulting sample was briefly centrifuged and then
subjected to SDS-PAGE and autoradiography. One
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control for this immunoprecipitation assay lacked the
ligand Ins, one was supplemented with 100-fold ex-
cess unlabeled membrane proteins, and another one
was treated with an antibody against cI a repressor
.  .protein of phage l Pharmacia , rather than against
Ins.
2.8. Affinity chromatography of receptor for Ins
An Ins affinity column was prepared by coupling 1
mg Ins to a CNBr-activated Sepharose 4B Column 1
.ml capacity, Pharmacia according to the manufac-
turer’s instructions. After the column was washed
with affinity-column elution buffer and subsequently
equilibrated with binding buffer, solubilized 125I-
membrane proteins were injected into the affinity
column and incubated at 48C for 2 h. Then the
column was washed with binding buffer until the
radioactivity in the effluent approached the back-
ground. The bound 125I-receptor was eluted from the
column using affinity-column elution buffer contain-
ing 0.01% Ins. The eluate was concentrated using a
Centricon-30 concentrator unit and analyzed by
SDS-PAGE.
2.9. Affinity crosslinking conditions
Conditions for crosslinking varied among experi-
ments and can be found in the legends of figures. In
general, the concentration of crosslinking reagents
used was 5 mM and crosslinking time was 1 h at
room temperature.
w125 xFor crosslinking of I Ins to crude oocyte mem-
brane preparations, the membrane preparations were
w125 xfirst incubated with I Ins, in 100 ml binding buffer
at 48C for 2 h, in the presence or absence of 150-fold
excess unlabeled Ins. The incubations were washed
with binding buffer twice to remove unbound
w125 xI Ins. The pellets were resuspended in 100 ml of
 .0.1 M Hepes buffer pH 7.5 . The appropriate cross-
linking reagent dissolved in DMSO was added so that
the final concentration of DMSO was 5%. Crosslink-
ing reactions were stopped by Tris buffer final con-
.centration of 20 mM, pH 8.5 . CHAPS detergent was
then added to a final concentration of 40 mM and
incubated on ice for 1 h to solubilize membrane
proteins.
The crosslinking of 125I-membrane proteins to Ins
was carried out in the same way as described above,
except that both components were incubated in 50 ml
binding buffer, in the presence or absence of 100-fold
excess unlabeled membrane proteins. After incuba-
tion of 125I-membrane with Ins, to each reaction was
 .added 50 ml of 0.2 M Hepes buffer pH 7.5 and
crosslinking reagent. Crosslinking reactions were
stopped as described above and the crosslinking
reagent was removed by ultrafiltration to minimize
the possible crosslinking of 125I-membrane proteins
to antibody or protein-A components. The resulting
sample was then used for immunoprecipitation exper-
iment as described previously.
2.10. Electrophoresis and autoradiography
Reducing SDS-PAGE was carried out basically
w xaccording to Laemmli 22 . When 1–30% gradient
gels were used, a modification was made in that 0.5%
 .of agarose low melting point grade was included in
the lower concentration gel preparation and stacking
 .gel 1% . After electrophoresis, the gels were ex-
posed to Kodak XAR-5 film at y808C to obtain an
autoradiogram. Kaleidoscope protein molecular
 .  .weight markers Bio-Rad and IgM 970 kDa, Pierce
were used to estimate the protein sizes of interest.
2.11. Computations
The dissociation constant, K ligand concentra-d
.tion at which receptor is half-saturated and Bmax
maximum specific binding per unit membrane pro-
.teins in this study were estimated by fitting satura-
tion binding curves using the built-in equations from
TM the software GraphPad Prism 1994, GraphPad
.Software, San Diego . Molarities were calculated as-
suming the molecular masses of the proteins as fol-
w x w xlows: Ins, 88 000 16 ; vitellogenin, 500 000 19 ; and
w xlipophorin, 420 000 23 .
3. Results
3.1. Optimization of ligand–receptor interaction
In order to obtain the optimal conditions for the
interactions between Ins and its solubilized receptor,
we first carried out experiments to determine the time
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required for the binding to reach equilibrium, the
optimal pH values and the requirement of Ca2q for
the binding. As shown in Fig. 1a, the binding in-
creased rapidly over the first 30 min and reached
equilibrium in about 90 min while the nonspecific
binding, determined by including a 75-fold excess of
unlabeled Ins in parallel incubations, did not increase
over the same period. The binding of Ins to the
receptor varied with pH: the optimal pH was approxi-
 . 2qmately 7.0 Fig. 1b . Ca was required for the
formation of receptor–Ins complex in that the spe-
cific binding increased with Ca2q concentrations of
up to 5 mM, while this increase in Ca2q concentra-
 .tion did not affect the nonspecific binding Fig. 1c .
When the solubilized membrane proteins were heated
at 808C for 15 min prior to incubation with Ins, the
specific binding capacity was greatly diminished Fig.
.1d . The subsequent binding assays were therefore
performed for 90 min, at 48C, pH 7.0, and with 5 mM
Ca2q in the binding buffer.
3.2. Binding properties of the solubilized Ins receptor
When a fixed amount of solubilized oocyte mem-
brane proteins was incubated with increasing amounts
w125 xof I Ins under equilibrium conditions, the specific
binding exhibited a saturable mode while the nonspe-
cific binding increased very slowly in a linear manner
 .Fig. 2a . The apparent K and the B , given byd max
the saturation curve fitting, were 17 nM and 11.4
pmolrmg solubilized membrane proteins, respec-
tively. The results were very close to those estimated
w xfrom Scatchard plot 24 , as shown in the inset of Fig.
2a. On the other hand, when a fixed amount of
w125 xI Ins was incubated with increasing amounts of
membrane proteins, the specific binding increased
 .linearly Fig. 2b .
Competition between Ins and two other hemolymph
proteins, vitellogenin and lipophorin, both of which
are also taken up by the developing oocytes via
w xmembrane-associated receptors 20,25 , was exam-
ined by incubating membrane proteins with radioac-
tively labeled Ins and excess molar concentration of
unlabeled vitellogenin or high density lipophorin. The
results shown in Fig. 3a indicated that these two
major hemolymph proteins had no apparent binding
affinity for the Ins receptor. In order to test the tissue
specificity of Ins for its receptor, solubilized mem-
 .Fig. 1. Parameters affecting binding of Ins to its receptor. a
Time dependence: in each tube, 2 mg of solubilized membrane
w125 x  .proteins and 2 mg I Ins 900000 cpmrmg were incubated in
 .binding buffer pH 7 at 48C for indicated time intervals. Nonspe-
cific binding was determined by including 75-fold excess unla-
beled Ins in a parallel incubation. The specific binding was
calculated as the difference between the total and nonspecific
binding. The circles represent specific binding and squares repre-
sent nonspecific binding. The data points are the means"S.D. of
three determinations. The incubation and washing conditions for
b, c and d were the same as for a, except for incubation time
 .being 90 min and other changes as indicated. b pH dependence:
pH values were varied using a 20 mM MES-Tris buffer system.
 . 2q 2qc Effect of Ca : For 0 mM concentration, Ca was chelated
with 5 mM EGTA. The solid columns stand for specific binding
 .and the open columns for nonspecific binding. d Test of heat
lability: the membrane proteins of one mixture were heated at
808C for 15 min prior to incubation.
brane proteins from other tissues of M. sexta, fat
body, midgut and ovariole sheath, were prepared and
tested for binding of Ins. As shown in Fig. 3b, the
total binding of these preparations were less than
15% as effective as oocyte membrane proteins for
binding Ins, which is equivalent to nonspecific back-
ground binding.
3.3. Visualization of Ins receptor using co-immuno-
precipitation and SDS-PAGE
Because repeated attempts to visualize the receptor
for Ins by ligand blotting have failed, we adapted a
co-immunoprecipitation strategy reported by Kessler
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w125 xFig. 2. Concentration-dependent binding of I Ins to its recep-
 . w125 xtor. a Constant membrane protein vs. varied I Ins concentra-
tions. 2 mg solubilized membrane proteins and increasing amounts
w125 xof I Ins were incubated in binding buffer at 48C for 90 min.
Triangles represent specific binding and circles represent nonspe-
cific binding. Data points are the means"S.D. of three determi-
nations. Through the fitted curve for specific binding, K equi-d
. librium dissociation constant and B maximum specific bind-m
.ing were estimated as 17 nM and 11.4 pmolrmg solubilized
membrane proteins respectively. A Scatchard plot of specific
 . w125 xbinding data is given in the inset. b Constant I Ins vs. varied
w125 xmembrane protein concentrations. 0.2 mg of I Ins and the
indicated amounts of solubilized membrane proteins were incu-
bated in the binding buffer at 48C for 90 min. Triangles stand for
specific binding, solid circles stand for nonspecific binding.
Nonspecific binding was determined by including 75-fold excess
unlabeled Ins in a parallel incubations. The specific binding was
calculated as the difference between the total and nonspecific
binding. Data points are the means"S.D. of three determina-
tions.
w x26 , which exploits the binding affinity between two
proteins and the affinity of one of the proteins for its
antibody. In our procedure, Ins was first incubated
with solubilized 125I-membrane proteins. Then anti-
bodies against Ins were added to form a non-covalent
receptor–ligand–antibody complex. This immune
complex was then precipitated using protein-A
agarose gel which has high affinity for the Fc portion
of IgG. The unbound radioactive membrane proteins
were removed by repeated washing of the protein-A
gel using binding buffer, while the bound protein
complex was readily dissociated from protein-A by
SDS-PAGE sample buffer. On the autoradiogram
derived from a 4–20% gradient SDS-PAGE gel, the
selectively enriched membrane proteins gave a
prominent band at the position of 185 kDa Fig. 4A,
.lane 1 . The presence of 150-fold excess of unlabeled
oocyte membrane proteins effectively diminished this
 .band Fig. 4A, lane 2 . In our preliminary experi-
Fig. 3. Ligand selectivity and tissue specificity of Ins receptor.
 . w125 xa Competition of I Ins by unlabeled hemolymph proteins for
binding to Ins receptor. 2 mg solubilized membrane proteins and
w125 x  .0.2 mg I Ins 900000 cpmrmg were incubated in the pres-
ence of 20 mg of one of the unlabeled proteins as indicated, at
48C for 90 min. Cont, control, without addition of unlabeled
 .protein; Vg, vitellogenin; Lp, lipophorin. b Tissue specificity in
w125 x  .binding of Ins to its receptor. 0.2 mg I Ins 900000 cpmrmg
was incubated with 2 mg of the solubilized membrane proteins
from different tissues of M. sexta as indicated at 48C for 90 min.
Ot, oocyte; Fb, fat body; Mt, midgut; Os, ovariole sheath. The
data points are the means"S.D. of three determinations.
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w125 x  .Fig. 4. SDS-PAGE of I Ins–receptor complex. A 10 mg of
125  5 .solubilized I-membrane proteins 14P10 cpmrmg were pre-
treated with antibody against Ins and Protein A gel as described
in Section 2 to remove any Ins bound to membrane proteins. The
resulting final solution was divided into four equal parts, 100 ml
each, and used for the following experiments. Lane 1: 125I-
solubilized membrane proteins were incubated with 0.2 mg Ins in
200 ml binding buffer supplemented with 5 mM CHAPS, at 48C
for 90 min. Then 20 ml of antibody against Ins was added to the
incubation mixture and incubated for 2 h at 48C followed by
 .addition of 50 ml of Protein-A slurry 50% in binding buffer .
The incubation was continued at 48C for 2 h and Protein-A gel
was pelleted by brief centrifugation. The resultant pellet was
 .washed repeatedly with binding buffer 4–5 times until the
radioactivity of the effluent was barely detectable. 50 ml SDS-
PAGE sample buffer was added to the Protein-A pellet and
mixed by vortexing. The mixture was centrifuged briefly and the
supernatant was loaded onto a 4–20% gradient gel to resolve the
receptor–Ins–antibody immune complex. The electrophoresis was
carried out at a constant voltage of 200 V for 3 h. The gel was
autoradiographed at y808C for 24 h. The band which appears to
be at 185 kDa is believed to be the Ins receptor. The treatments
for the samples presented in the other lanes were the same as for
lane 1, but with a change for each incubation as described in the
following. Lane 2: 150 mg unlabeled solubilized oocyte mem-
brane proteins were included in the incubation. Lane 3: Ins was
omitted in the incubation. Lane 4: antibody against Ins was
 .replaced by that against cI a prokaryotic protein . Lane 5: was
125  5loaded with 25 ng of I-solubilized membrane proteins 14P10
.  . 125cpmrmg . B 20 mg of I-solubilized membrane proteins
 .25 000 cpmrmg were injected into the Ins-affinity column and
washed. The bound receptor was then eluted as described in
Section 2. The eluted radioactivity accounted for some 0.1% of
the total amount injected. The eluate was concentrated using a
 .Centricon-30 Amicon and loaded onto 4–20% gradient SDS-
PAGE gel, and electrophoresed at a constant voltage of 200 V for
3 h. The gel was autoradiographed at y808C for 96 h.
ments, a control in which no exogenous Ins was
added to the incubation, a weaker band was inconsis-
tently observed at the position where the Ins receptor
 .was identified data not shown . We reasoned this
band might be caused by endogenous Ins which
remained bound to membrane proteins during the
process of solubilizing membrane proteins. When the
125I-membrane proteins were thoroughly pretreated
with antibodies against Ins, this background was
 .eliminated Fig. 4A, lane 3 . In order to see if the
band denoting putative Ins receptor was an artifact
caused by radioactively labeled high molecular mass
proteins which might be nonspecifically bound to
antibodies, a control in which the antibodies against
Ins were replaced by an antibody against a protein of
phage l was performed. The result revealed that the
signal was not caused by nonspecific binding of
125 I-membrane component to antibodies Fig. 4A,
. 125lane 4 . Moreover, the I-membrane protein eluted
from the Ins-affinity column gave a single band on
SDS-PAGE gel, which had the same size as detected
 .before Fig. 4B . From these data we conclude that
this 185 kDa protein is, or is part of, the oocyte
receptor for Ins.
3.4. Crosslinking of Ins to its receptor
In order to obtain further information about the
Ins–receptor complex, the receptor was covalently
w125 xcrosslinked to I Ins and analyzed by SDS-PAGE.
Initially we tested the effects of three commonly used
3  .crosslinkers: DSS, DTSP and BS Pierce , on cross-
linking of 125Ins to its oocyte membrane receptor.
The results showed that both DSS and DTSP were
w125 xeffective in crosslinking I Ins to critical mem-
 . 3brane component s while BS was quite inefficient
 .data not shown . The extent of the crosslinking
increased with time of exposure and the concentra-
tion of the reagent. Exposure to 5 mM reagent for 1 h
 .appeared to be optimal data not shown . Considering
the high efficiency and low cost, we chose to use
DSS as crosslinker for the rest of crosslinking experi-
w125 xments. I Ins was first incubated with crude oocyte
membrane preparations as described in the legend of
w125 xFig. 5. After unbound I Ins was removed by
w125 xcentrifugation, the I Ins–receptor complex was
chemically crosslinked by incubation with DSS. The
mixture was then solubilized, separated by SDS-
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w125 xFig. 5. Reciprocal crosslinking of I Ins to membrane proteins
and 125I-solubilized membrane proteins to Ins. Binding reactions
were performed at 48C for 2 h. Crosslinking reactions were
carried out at room temperature for 1 h, followed by addition of
 .Tris pH 8.5 to a final concentration of 20 mM to stop cross-
 .linking. 100 ml SDS-PAGE sample buffer non-reducing was
added to each sample, boiled for 15 min and subjected to 1–30%
gradient SDS-PAGE. Kaleidoscope protein marker and IgM were
run in a parallel lane as molecular weight standards. A constant
voltage of 200 V was applied for 8 h. Finished gel was subjected
to autoradiography at y808C for 20 h. Lanes 1 to 3 show
w125 xcrosslinking of I Ins to membrane proteins where each reac-
w125 x  .tion contained 5 ml of I Ins 0.43 mgrml, 900000 cpmrmg ,
 .2 ml membrane proteins 1.5 mgrml or other component as
indicated in the figure. For lanes 4 to 6, the reaction mixture was
precipitated with antibodies to Ins, and the precipitate was loaded
on the gel. These lanes exhibit the crosslinking of 125I-membrane
proteins to Ins where each reaction contained 0.2 mg 125I-mem-
brane proteins, 0.5 mg Ins or other component as indicated in the
figure. DSS, the addition of DSS with a final concentration of 5
mM after binding reaction; Excess Ins, the addition of 150-fold
excess unlabeled Ins; Excess Membrane proteins, addition of
100-fold excess unlabeled membrane proteins. In the reactions
corresponding to lane 1 and lane 4, DSS was substituted by equal
 .volume 5 ml of the solvent DMSO.
PAGE electrophoresis and autoradiographed. Several
bands were detected on the autoradiogram Fig. 5,
.lane 2 . The band at the top, with similar molecular
 .mass to IgM 970 kDa corresponded to the
w125 xI Ins–receptor complex since it was eliminated by
 .excess unlabeled Ins Fig. 5, lane 3 . The other 4
 .bands Fig. 5, lanes 2 and 3 , ranging from 22 kDa to
w125 x88 kDa, represent the I Ins monomer, dimer, trimer
and tetramer respectively. In order to confirm the
receptor identity of the species with high molecular
mass, we reciprocally crosslinked 125I-membrane pro-
teins to Ins, followed by immunoprecipitation of the
Ins–receptor complex and electrophoretic analysis, as
described above. This identified an Ins–receptor
 .complex Fig. 5, lane 5 , with the same mobility on
gel as identified by the alternative crosslinking Fig.
.5, lane 2 and this band could be specifically com-
peted out by excess unlabeled membrane proteins
 .Fig. 5, lane 6 . When only the solvent DMSO was
included in the reaction mixture, neither intramolec-
ular nor intermolecular crosslinking occurred Fig. 5,
.lanes 1 and 4 . However, the band of 185 kDa was
present in Fig. 5, lane 4 where no crosslinking took
place, since the 125I-receptor for Ins was still co-im-
munoprecipitated.
4. Discussion
The M. sexta larva is provided with a perfect
coloration to camouflage it among the green plants of
w xits habitat 10 . The tint is produced by combining
 .dietary carotenoids especially lutein with an en-
dogenous blue biliprotein, Ins. Ins is produced in
w xlarval epidermis 11 and is abundant in the
hemolymph. During the adult life of the female, Ins,
along with yellow pigments, is sequestered into the
developing oocyte to provide the mature eggs with a
protective green coloration by allowing them to blend
in with the color of the leaf on which they are
deposited.
Hemolymph proteins are internalized into develop-
ing insect oocytes largely via receptor-mediated en-
w xdocytosis 2,3,5 . The initial event in this endocytosis
is thought to be binding of the proteins to a specific
oocyte surface protein or receptor. There is, there-
fore, great interest to identify these receptor species
and to study their interactions with ligand proteins
and other possible membrane components. For the
Ins receptor, much information has been gathered by
 w xclassical binding studies and other assays Ref. 1 ;
.this study .
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The solubilized Ins receptor exhibited the common
features shared by the insect receptors so far identi-
w xfied 5 . Binding of Ins to this solubilized receptor
was saturable over time, which basically differed
from the mode of nonspecific binding. This binding
depended on the pH, with optimal pH in proximity of
7.0. Ca2q increased binding of Ins to its receptor,
suggesting that it is important to the ligand–receptor
complex formation. Heating of the solubilized recep-
tor abolished binding of Ins, indicating that the recep-
tor is a protein.
It was reported that in another lepidopteran insect,
Hyalophora cecropia, the same receptor that is re-
sponsible for vitellogenin uptake may also bind the
w xmajor hemolymph lipoprotein, lipophorin 27 . The
electron microscopic observation of endocytotic path-
way of several proteins including vitellogenin and
w xlipophorin has been described in M. sexta 28 .
Therefore it is of interest to investigate if the endocy-
tosis of Ins shares a common mechanism with the
uptake of vitellogenin or lipophorin. Our results indi-
cated that the endocytotic receptor for Ins is distinct
from that for vitellogenin or lipophorin, as the bind-
ing of Ins to its receptor is not affected by the
presence of excess vitellogenin or lipophorin of M.
sexta. It was also observed that in M. sexta vitel-
logenin and lipophorin did not compete for binding to
w xoocyte membranes 20,25 . The Ins–receptor interac-
tions also exhibit explicit tissue specificity: a signifi-
w125 xcant amount of I Ins is only bound to membrane
proteins from the developing oocyte, not to solubi-
lized membrane proteins from fat body, midgut or
ovariole sheath of M. sexta. These findings are con-
sistent with data we previously reported on the bind-
w xing of Ins to crude oocyte membranes 1 .
The dissociation constant K of 17 nM determinedd
with solubilized membrane proteins was lower than
 . w xthat 40 nM with crude membrane extracts 1 . We
postulate that the removal of nonspecific Ins binding
sites by the solubilization process may account, at
least in part, for this lower K value. Actually thed
phenomenon that an increase in relative purity of
receptor proteins is associated with a decrease in Kd
value has been reported for the vitellogenin receptor
w x w xof the locust 29,30 , mosquito 7,31,32 and chicken
w x33 .
We estimated the apparent molecular size of Ins
receptor as 185 kDa by co-immunoprecipitation and
SDS-PAGE analysis. This size is comparable to that
w xfor a mosquito vitellogenin receptor of 205 kDa 7
w xand a locust vitellogenin receptor of 180 kDa 6 , but
different from that for a fat body lipophorin receptor
w xof 120 kDa in M. sexta 9 . Ligand blotting has been
employed in some insects to estimate the apparent
w xsizes of receptors in eggs for L. migratoria 6 ,
w x w xSchistocerca gregaria 34 , Nauphoeta cinerea 35
w xand Aedes aegypti 7,32 , and receptor in fat body
w xfor M. sexta 9 . A common feature of the above
reported receptors is that the intactness of certain
disulfide bonds is necessary for the ligand–receptor
interaction, as only in the absence of reducing agents
such as 2-mercaptoethanol or dithiothreitol, were the
ligands able to bind to their receptors on blots. How-
ever, we did not succeed in visualizing the Ins recep-
tor by following or modifying the published proce-
dures for ligand blotting. One of the possible causes
for this failure might be that when the Ins receptor is
denatured in the SDS-PAGE, it does not refold into a
native structure as exactly as other receptors even
after SDS is removed, and thus no longer binds to its
ligand. Therefore we adapted the strategy of co-im-
munoprecipitation which has been widely used in
receptor studies in vertebrates. This method exploits
several advantages: Ins–receptor binding under opti-
mum conditions, the high specificity of Ins for anti-
body, the high affinity of protein-A for IgG and the
expediency of SDS-PAGE analysis for resolving the
immune complex. This circumvents the technical dif-
ficulty in binding Ins to the denatured or incom-
pletely renatured receptor on blotting membranes.
This technique may be especially useful when a
receptor possesses a structure of noncovalently asso-
ciated homo- or hetero-oligomers and the cooperativ-
ity of the subunits is a requirement for its binding to
ligand, where the ligand blotting is obviously not
applicable.
Further information on the Ins–receptor interaction
was obtained by chemical crosslinking experiments.
To our knowledge, this was the first time that this
method was used in the study of an insect receptor.
Chemical crosslinking is a valuable tool to study the
protein–protein interaction and has been extensively
applied to gather information about the sizes and
spatial organizations of receptors in mammalian
w xspecies 36 . Many parameters of the crosslinking
reagent, such as the nature of reactive groups, the
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length of arm between reactive groups, solubility or
chemical stability, could play a part in determining if
a crosslinking reaction is successful. In this study we
have tested three commonly used homobifunctional
 .NHS N-hydroxysuccinimidyl -ester crosslinkers:
DSS, DTSP and BS3 for their effects on crosslinking
Ins to its receptor. DSS and DTSP are water-immisci-
ble while BS3 is water-soluble. Our results revealed
that DSS and DTSP are effective in crosslinking Ins
to its membrane receptor, while the efficiency of BS3
was poor.
w125 xWhen I Ins was crosslinked to its binding site
on M. sexta oocyte membranes and analyzed on
SDS-PAGE gel, the apparent molecular mass of the
crosslinked species was approximately 1000 kDa.
This high molecular mass band was eliminated by
including excess unlabeled Ins, which indicated the
interaction between the ligand and receptor was spe-
cific. More convincingly, when 125I-membrane pro-
teins from M. sexta oocytes were reciprocally
crosslinked to Ins, followed by immunoprecipitation
with antibodies against Ins and SDS-PAGE analysis,
a species of the same size was detected, which was
also competed out by excess unlabeled membrane
proteins. A possible interpretation of these results is
that the Ins receptor is composed of several probably
.four subunits. It is common that endocytotic recep-
tors in their native state possess multimeric organiza-
tion which may be held together through disulfide
w xlinkages or through non covalent interaction 37 . The
human transferrin receptor, for example, is a disul-
w xfide-linked homodimer 38 while the mammalian
 .low-density lipoprotein receptor LDLR and the
chicken hepatic lipoprotein receptor are non-covalent
w xoligomers 37,39 . An oligomeric structure was also
observed for the mosquito oocyte vitellogenin recep-
w xtor 7 . A second possibility is that the receptor is
normally monomeric, but when it binds one of the
four identical Ins subunits, it clusters with other
receptors which bind the additional subunits of a
single Ins molecule, resulting in four receptors bind-
ing to one Ins molecule. This would be similar to the
electron microscopic observation made by Delain et
al. in that two and three a -macroglobulin receptors2
simultaneously binding to its tetrameric ligand in
w xsolution 40 . Further characterization of the Ins re-
ceptor will be necessary before we can decide be-
tween these possibilities.
In summary, we have solubilized M. sexta oocyte
receptor for Ins, characterized its binding properties
and visualized apparent molecular size of this recep-
tor and its possible higher-order structure. The infor-
mation obtained through this study will help to de-
sign methods for purification or molecular cloning of
the receptor.
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